Scott C. Meixner

477 total citations
12 papers, 381 citations indexed

About

Scott C. Meixner is a scholar working on Hematology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Scott C. Meixner has authored 12 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Scott C. Meixner's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Blood properties and coagulation (6 papers). Scott C. Meixner is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Blood properties and coagulation (6 papers). Scott C. Meixner collaborates with scholars based in Canada, United States and Germany. Scott C. Meixner's co-authors include Edward L.G. Pryzdial, Edward M. Conway, Timothy Myles, Verena Goebeler, Zhen Lu, Michael J. Krisinger, Andrew Churg, James R. Wright, Xiaoshan Wang and Christian J. Kastrup and has published in prestigious journals such as Blood, Scientific Reports and Thrombosis and Haemostasis.

In The Last Decade

Scott C. Meixner

12 papers receiving 378 citations

Peers

Scott C. Meixner
Jecko Thachil United Kingdom
Zohra Ahmadi Australia
Muhua Cao China
Kristina M. Haley United States
Coralie Pennaneac'h United Kingdom
Jecko Thachil United Kingdom
Scott C. Meixner
Citations per year, relative to Scott C. Meixner Scott C. Meixner (= 1×) peers Jecko Thachil

Countries citing papers authored by Scott C. Meixner

Since Specialization
Citations

This map shows the geographic impact of Scott C. Meixner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott C. Meixner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott C. Meixner more than expected).

Fields of papers citing papers by Scott C. Meixner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott C. Meixner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott C. Meixner. The network helps show where Scott C. Meixner may publish in the future.

Co-authorship network of co-authors of Scott C. Meixner

This figure shows the co-authorship network connecting the top 25 collaborators of Scott C. Meixner. A scholar is included among the top collaborators of Scott C. Meixner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott C. Meixner. Scott C. Meixner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Eltringham‐Smith, Louise J., Scott C. Meixner, Edward L.G. Pryzdial, & William P. Sheffield. (2023). Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice. Scientific Reports. 13(1). 3811–3811. 1 indexed citations
2.
Meixner, Scott C., Kevin C. Gonzalez, Houra Loghmani, et al.. (2021). CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models. Journal of Thrombosis and Haemostasis. 19(8). 1932–1947. 8 indexed citations
3.
Meixner, Scott C., Jerry Leung, Jayesh A. Kulkarni, et al.. (2020). Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency. Blood. 136(25). 2946–2954. 25 indexed citations
4.
Meixner, Scott C., J. Grace van der Gugten, Daniel T. Holmes, et al.. (2018). Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity. Journal of Thrombosis and Haemostasis. 16(11). 2276–2288. 40 indexed citations
5.
Pryzdial, Edward L.G., Scott C. Meixner, Louise J. Eltringham‐Smith, et al.. (2016). Thrombolysis by chemically modified coagulation factor Xa. Journal of Thrombosis and Haemostasis. 14(9). 1844–1854. 6 indexed citations
6.
Meixner, Scott C., et al.. (2013). Proteolytic modulation of factor Xa–antithrombin complex enhances fibrinolysis in plasma. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1834(6). 989–995. 8 indexed citations
7.
Meixner, Scott C., et al.. (2012). Herpesviruses enhance fibrin clot lysis. Thrombosis and Haemostasis. 107(4). 760–768. 8 indexed citations
8.
Krisinger, Michael J., Verena Goebeler, Zhen Lu, et al.. (2012). Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. Blood. 120(8). 1717–1725. 159 indexed citations
9.
Meixner, Scott C., et al.. (2011). Factor Xa-Antithrombin Complex Enhances Tissue Plasminogen Activator-Mediated Clot Lysis. Blood. 118(21). 1180–1180. 1 indexed citations
10.
Meixner, Scott C., et al.. (2009). Enhanced fibrinolysis by proteolysed coagulation factor Xa. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1804(4). 723–730. 15 indexed citations
11.
Churg, Andrew, et al.. (2007). α1-Antitrypsin Suppresses TNF-α and MMP-12 Production by Cigarette Smoke–Stimulated Macrophages. American Journal of Respiratory Cell and Molecular Biology. 37(2). 144–151. 103 indexed citations
12.
Hancock, Mark A., et al.. (2007). Plasminogen binds to plasmin-modulated factor Xa by Ca2+- and C-terminal lysine-dependent and -independent interactions. Thrombosis and Haemostasis. 97(1). 38–44. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026